The Advanced Genomics Collaboration
The Advanced Genomics Collaboration

News & Events

On a mission to help oncologists diagnose a mysterious, aggressive cancer
News
Oct 14, 2024
1
 min read
On a mission to help oncologists diagnose a mysterious, aggressive cancer
A case study developed by Illumina has highlighted a TAGC funded project led by collaborators at the University of Melbourne and Peter MacCallum Cancer Centre developing a liquid biopsy test for cancer of unknown primary.
TAGC Innovation Projects highlighted on RRR
News
Aug 1, 2024
1
 min read
TAGC Innovation Projects highlighted on RRR
The Advanced Genomics Collaboration's four 2024 Innovation Projects went live on RRR's Einstein A Go-Go radio program—a program exploring the wonders of science and its impact on the world.
Welcome Professor Gang Chen, lead of TAGC's Health Economics Platform
News
Jul 18, 2024
3
 min read
Welcome Professor Gang Chen, lead of TAGC's Health Economics Platform
Professor Gang Chen has joined the University of Melbourne as Professor, Cancer Health Services Research, and will lead TAGC's Health Economics Platform.
Genomics-focused biomedical research secures $6.5 million to address complex health challenges
News
Mar 19, 2024
2
 min read
Genomics-focused biomedical research secures $6.5 million to address complex health challenges
The Advanced Genomics Collaboration (TAGC) has awarded funding to four new Innovation Projects led by University of Melbourne researchers collaborating with partners across the Melbourne Biomedical Precinct.
A better way to diagnose and treat prostate cancer
News
Mar 18, 2024
1
 min read
A better way to diagnose and treat prostate cancer
A trial using genomic testing and predictive disease modelling to guide therapy and reduce the burden of prostate cancer diagnosis, which evidence suggests is over-diagnosed and over-treated in early disease.
Enabling new therapies to stop blindness
News
Mar 18, 2024
1
 min read
Enabling new therapies to stop blindness
Establishing a comprehensive patient dataset of inherited retinal diseases, providing information to drive new treatments and therapies for the most common cause of blindness in working-aged Australians.

Increasing genomics innovation and its translation and adoption into the healthcare system to improve patient outcomes.